Evidence map›Paper›PMID 31683833›Full record

ReviewMetabolites2019

A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery.

Uttpal Anand, Nadia Jacobo-Herrera, Ammar Altemimi, Naoufal Lakhssassi

Open access · goldAbstract readReview
In one paragraph

Review in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 260 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
260citing papers in PubMed, 1 pooled it
67.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

260 citing papers in PubMed, 1 synthesis or guideline pooled it, 828 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Antibacterial and Antibiofilm Activities of Bluestem (International journal of microbiology · 2026
    Article
  20. Antimicrobial Resistance: The Answers.British journal of biomedical science · 2026
    Review

200 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Uttpal AnandDepartment of Molecular and Cellular Engineering (MCE), Jacob Institute of Biotechnology and Bioengineering (JIBB), Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj (Allahabad), Uttar Pradesh 211007, India. ushuats@gmail.com.ORCID 0000-0001-5924-7866
Nadia Jacobo-HerreraUnidad de Bioquímica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Av. Vasco de Quiroga 15. Col. Belisario Domínguez Sección XVI. C.P. Tlalpan, Ciudad de México 14080, Mexico. nadia.jacobo@gmail.com.
Ammar AltemimiDepartment of Food Science, College of Agriculture, University of Basrah, Basrah 61004, Iraq. ammaragr@siu.edu.ORCID 0000-0001-7750-5988
Naoufal LakhssassiDepartment of Plant, Soil and Agricultural Systems, Southern Illinois University, Carbondale, IL 62901, USA. naoufal.lakhssassi@siu.edu.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXSam Higginbottom Institute of Agriculture · INSouthern Illinois University Carbondale · USUniversity of Basrah · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The war on multidrug resistance (MDR) has resulted in the greatest loss to the world's economy. Antibiotics, the bedrock, and wonder drug of the 20th century have played a central role in treating infectious diseases. However, the inappropriate, irregular, and irrational uses of antibiotics have resulted in the emergence of antimicrobial resistance. This has resulted in an increased interest in medicinal plants since 30-50% of current pharmaceuticals and nutraceuticals are plant-derived. The question we address in this review is whether plants, which produce a rich diversity of secondary metabolites, may provide novel antibiotics to tackle MDR microbes and novel chemosensitizers to reclaim currently used antibiotics that have been rendered ineffective by the MDR microbes. Plants synthesize secondary metabolites and phytochemicals and have great potential to act as therapeutics. The main focus of this mini-review is to highlight the potential benefits of plant derived multiple compounds and the importance of phytochemicals for the development of biocompatible therapeutics. In addition, this review focuses on the diverse effects and efficacy of herbal compounds in controlling the development of MDR in microbes and hopes to inspire research into unexplored plants with a view to identify novel antibiotics for global health benefits.

Indexed as

antibioticsantimicrobial resistantimmune responseinfectious diseasesecondary metabolites

Identifiers

PMID31683833
PMCPMC6918160
OpenAlexW2987783202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.